Website profile

@Genbio

Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

  • 774articles · 180d
  • 2+ day agolatest article
  • Mar 17, 2026earliest in window
  • 97%with images
  • 312avg words
articles per day
Categories
  • Science & Technology 516
  • Science & Nature 442
  • Health & Wellness 407
  • Medical 265
  • Business & Industrial 184
  • Health 163
  • STEM 148
  • Economy, Business & Finance 78

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@genbio
genengnews.com > topics > bioprocessing > probiogen-grants-transgene-additional-license-for-age1-cr-pix-cell-line

ProBioGen Grants Transgene Additional License for AGE1.CR.pIX Cell Line

4+ day, 6+ hour ago   (302+ words) ProBioGen and Transgene report that they broadened the scope of their existing collaboration to include an additional license agreement for ProBioGen’s suspension AGE1.CR.plXR cell line which is designed to boost Transgene’s manufacturing capabilities with this specialized production technology. ProBioGen…...

@genbio
genengnews.com > topics > omics > rnav8-bio-joins-arpa-h-team-to-pioneer-programmable-rna-medicines

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

4+ day, 7+ hour ago   (207+ words) RNAV8 Bio (pronounced Renovate Bio) has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA-H) for PROPEL (Programmable RNA for Optimal Precision in Therapeutic Efficacy and Localization). “Just as important, every element we discover stays answerable…...

@genbio
genengnews.com > topics > drug-discovery > moonwalk-to-use-70-million-to-develop-rnai-therapies-for-obesity-cardiometabolic-disease

Moonwalk to Use $70 Million to Develop RNAi Therapies for Obesity, Cardiometabolic Disease

4+ day, 10+ hour ago   (475+ words) Genetic Engineering and Biotechnology News Biotech company Moonwalk Biosciences announced that it has raised $70 million from an oversubscribed series B financing round. The company plans to use the funds to continue developing its adipose-targeted RNAi therapies for obesity and cardiometabolic…...

@genbio
genengnews.com > topics > bioprocessing > newbiologix-and-synastra-join-forces-to-advance-raav-manufacturing-for-duchenne-gene-therapy

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

1+ week, 8+ hour ago   (259+ words) NewBiologix will use its Xcell™ stable manufacturing platform to generate and characterize a research cell bank for Synastra’s DMD gene therapy candidate. The agreement also provides an option to transition the program to a commercial license supporting future clinical and…...

@genbio
genengnews.com > topics > translational-medicine > navigating-the-regulatory-labyrinth-how-biotech-leaders-are-rethinking-strategy-in-an-uncertain-regulatory-era

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory Era

1+ week, 3+ day ago   (464+ words) By David H. Crean, PhD That is the environment biotech executives are navigating right now. The strategic responses being formulated quietly, deliberately, at the level of pipeline sequencing, capital allocation, and partnership architecture will shape the competitive landscape of biopharma for…...

@genbio
genengnews.com > topics > translational-medicine > darpa-awards-uc-san-diego-up-to-11-3-million-for-smarter-red-blood-cells

Darpa Awards UC San Diego Up to $11.3 Million for 'Smarter' Red Blood Cells

1+ week, 5+ day ago   (433+ words) Scientists at the University of California San Diego School of Medicine have been awarded a contract of up to $11.312 million from the Defense Advanced Research Projects Agency (DARPA) to pursue a research project aimed at developing optimized red blood cells…...

@genbio
genengnews.com > topics > bioprocessing > affordable-bioreactor-helps-prep-students-for-biomanufacturing-careers

Affordable Bioreactor Helps Prep Students for Biomanufacturing Careers

2+ week, 3+ day ago   (337+ words) The biomanufacturing workforce of the future is hampered by a lack of familiarity with the technology today. Consequently, when those students choose careers, biotech isn’t top of mind and, even when it is, they may not have developed the deep…...

@genbio
genengnews.com > topics > translational-medicine > in-massachusetts-latest-annual-snapshot-shows-a-tale-of-two-biopharmas

In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas

2+ week, 4+ day ago   (770+ words) Industry group MassBio’s report shows comebacks for VC, IPOs, and M&A activity—as well as funding challenges for startups and a three percent year-over-year decline in employment Massachusetts, the home of the nation’s leading biopharma cluster as ranked by…...

@genbio
genengnews.com > multimedia > podcasts > gencast > small-molecules-big-expectations-how-cdmos-are-helping-sponsors-navigate-complexity-speed-scale-up-and-sustainability

Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability

2+ week, 5+ day ago   (164+ words) In this sponsoredGEN Podcast – part 2 in a 3-part series -- a trio of experts from SK Pharmteco discuss how CDMOs are helping biopharma companies navigate critical areas including scale-up, technology transfer, advanced manufacturing, automation, sustainability, the emergence of AI, and supply chain…...

@genbio
genengnews.com > topics > drug-discovery > rznomics-joins-lilly-gateway-labs-to-quicken-rna-therapeutic-candidate-discovery-and-development

Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development

2+ week, 5+ day ago   (211+ words) Genetic Engineering and Biotechnology News Rznomics is joining Lilly Gateway Labs (LGL) in San Diego. The company is a clinical-stage biopharmaceutical firm based in South Korea focused on developing RNA-based gene therapies. Lilly Gateway Labs is an innovation hub designed…...